AMGEN Inc
NASDAQ: AMGN
$292.49
+$2.59 (+0.9%)
Real Time Data Delayed 15 Min.
AMGN Stock Chart and Intraday Price
AMGN Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 150,234.17M USD |
| Shares Outstanding | 535,919,000 |
AMGN Articles
24/7 Wall St. Insights: AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s pipeline, raising...
Published:
Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their shares into smaller slices. Walmart (NYSE:WMT) split its stock in February,...
Published:
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery...
Published:
These six top Dow Jones industrial average stocks are among the best dividend ideas for investors now, and all are rated Buy at top Wall Street firms.
Published:
24/7 Wall St. Insights Jefferies is one of Wall Street’s fastest-growing firms. Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500. Access 2 legendary,...
Published:
SCHD and VOO are two very popular ETFs for investors looking to diversify quickly. Like all ETFs, these two investment vehicles hold a “bucket” of stocks. However, the stocks they hold are very...
Published:
The artificial intelligence rally over the last year and a half, led by the so-called Magnificent 7, has been remarkable if you owned those stocks. However, most of the S&P 500 is treading water...
Published:
The Artificial Intelligence rally over the last year, led by the so-called “Magnificent 7,” has been fantastic if you owned those stocks. However, most of the S&P 500 is treading water and...
Published:
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
Published:
Here are some of the top upgrades, downgrades and other analyst calls for Thursday, December 21, along with other investing news.
Published:
Tuesday's most notable analyst upgrades and downgrades and other calls were on Amazon, PepsiCo, Netflix and more.
Published:
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
Published:
After years of a low-interest rate environment, which has reversed in a big way over the last 18 months, many investors continue to turn to equities not only for growth potential but also for solid...
Published:
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and...
Published:
Thursday's top analyst upgrades and downgrades included Amgen, Arista Networks, Boeing, Coherent, CSX, Netflix, Northrop Grumman, Shoals Technologies, Take-Two Interactive Software, Unilever and...
Published: